Sinovac Biotech from China seeks co-financing for COVID-19 vaccine trial in Bangladesh

▴ chinese-vaccine-company-sinovac-biotech-seeks-cofinancing-covid19-vaccine-trial-in-bangladesh
The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine

The Chinese vaccine company Sinovac Biotech has sought co-financing from Bangladesh for a phase-3 clinical trial of its COVID-19 vaccine.

The company was given permission to carry out the phase-3 human trial about a month back by the government.

Responding to an unconfirmed report about the Chinese company asking for co-financing for a vaccine trial, the Health Division Secretary of the government of Bangladesh Abdul Mannan confirmed to the official news agency BSS yesterday that Sinovac Biotech Ltd has sent a letter to the government seeking co-financing for COVID 19 vaccine trial.

He said that the company had not asked for co-financing by the Bangladesh government when it obtained the approval to carry out the trial.

The Chinese company had originally put up the proposal to Bangladesh through the Dhaka based International Centre for Diarrheal Disease Research, Bangladesh (ICDDR’B). The government granted final clearance for the clinical trial on August 27.

An official of the ICDDR’B told BSS that it is now entirely up to the government to decide if they will agree to the co-financing proposal as there was no mention of it in the original proposal of the Chinese company.

Under the agreement before the co-financing was sought, Bangladesh would have got one lakh vaccines for free. It would also have got priority to purchase adequate quantum of vaccines from the Chinese company Sinovac Biotech.

Meanwhile, Bangladesh Govt has issued directives restricting certain activities in view of the security, law and order and COVID-19 pandemic during the upcoming Durga Puja in the country. The directives came after the meeting Chaired by Home Minister Asaduzzamn Khan on Sunday in Dhaka.

The meeting requested the leaders of the nationwide Sarbajanin Puja Committee to limit the number of Puja mandaps as much as possible. The government has also decided that no procession will be allowed during the immersion of the idol at the end of the Durga Puja, said the press release issued by the Home Ministry.

The meeting decided that the Puja Celebration Committee will take steps to reduce the number of public gatherings at the Puja Mandap and to broadcast the Anjali program live. The organisers have been asked to maintain health guidelines such as social distancing, wearing of masks and using the hand sanitiser for people visiting the mandaps.

Police forces will be on mobile duty to deal with law and order situations. The guidelines also require that various ceremonies should be held maintaining religious harmony. The Puja Udjapan Committee will be coordinating with the local administration and law enforcement agencies for the management of the mandaps.

Tags : #SinivacBiotech #China #Bangladesh #COVID-19Vaccine #Phase-3Trial #LatestPharmaNews5thOct #LatestCOVIDNews5thOct

About the Author


Team Medicircle

Related Stories

Loading Please wait...

-Advertisements-




Trending Now

The Ethics of Live Surgery Broadcasts: NMC Seeks Public OpinionMay 17, 2024
Successful Removal of 3.7 KG Large Abdominal Tumor from 14-Year-Old Somalian Girl at KIMS Cuddles HospitalMay 16, 2024
iLEAD Sets a Precedent by Launching a Graphic Anthology Authored by Multimedia, Animation and Graphics Students May 16, 2024
Ramaiah Memorial Hospital Launches Novel Intra-Operative Radiation Therapy (IORT); Achieves significant advancement in Cancer Treatment to Enhance Quality of LifeMay 16, 2024
IIITH Announces Product Management Summer SchoolMay 16, 2024
Çelebi India's Delhi Cargo Terminal Successfully Handles Airbus H125 Helicopter ShipmentMay 16, 2024
Plant-Based Diets and Prostate Cancer: New UCSF Study Shows Promising ResultsMay 16, 2024
National Medical Commission Approves 112 New Medical CollegesMay 16, 2024
Study Suggests That Chemotherapy Results in Physical Decline for Older Women with Breast CancerMay 16, 2024
Google DeepMind's AlphaFold 3: Revolutionizing Drug Discovery with AIMay 16, 2024
Hester Biosciences Ltd reports Consolidated Revenue growth of 18% at Rs. 79.3 crore, EBITDA up 37% to Rs. 16.4 crore and Net Profit up 12% to Rs. 6.40 crore in Q4FY24May 16, 2024
Akshay Tritiya Parna Mahotsav heldMay 16, 2024
IT Minister Sridhar Babu to grace the 10th National Facilities Managers Summit-2024, to be held in the cityMay 15, 2024
Alarming Study Reveals Cancer-Causing Chemicals in Car InteriorsMay 15, 2024
India's Thalassemia Challenge: The Importance of Early Screening and TreatmentMay 15, 2024
The Dangers of Ultra-Processed Foods: A 30-Year Study Raises AlarmsMay 15, 2024
Unique Genetic Risk Factors for Breast Cancer Found in African Ancestry StudyMay 15, 2024
AsiaMedic partners with Sunway to establish new diagnostic imaging centreMay 14, 2024
Kamineni Doctors Successfully Remove Bone Stuck Near Heart in Elderly PatientMay 14, 2024
On International Nurses Day, American Oncology Institute (AOI) launches #TheExtraordinaryCareGiver Campaign as Tribute to Oncology NursesMay 14, 2024